Evidence map›Paper›PMID 39282224›Full record

ArticleJournal of oncology2023

Tracking Peripheral Memory

Pengyuan Kang, Hong Yu, Yunfei Li, Xue Wen, Hua Ye, Yuhao Luo, Yaqi Yang, Qing Yuan, Sheng Lin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pengyuan KangDepartment of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province 646000, China.
Hong YuPublic Center of Experimental Technology, The School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan Province 646000, China.
Yunfei LiDepartment of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province 646000, China.
Xue WenDepartment of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province 646000, China.
Hua YeDepartment of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province 646000, China.
Yuhao LuoDepartment of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province 646000, China.
Yaqi YangPublic Center of Experimental Technology, The School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan Province 646000, China.
Qing YuanPublic Center of Experimental Technology, The School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan Province 646000, China.ORCID https://orcid.org/0000-0002-5829-1328
Sheng LinDepartment of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province 646000, China.ORCID https://orcid.org/0000-0002-8133-4082

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypofractionated radiotherapy (HFRT) or chemotherapy combined with programmed death-1 (PD-1) blockade has achieved good clinical control in advanced nonsmall cell lung cancer (NSCLC). However, the relative influence of HFRT + PD-1 blockade and chemo-immunotherapy on peripheral memory T cell subsets in NSCLC responders has not been evaluated in clinical practice. Thirty-nine patients with advanced NSCLC were enrolled. The frequencies of naive (Tn; CD45RA

Identifiers

PMID39282224
PMCPMC11401694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.